Your browser doesn't support javascript.
loading
Biallelic pathogenic variants in the lanosterol synthase gene LSS involved in the cholesterol biosynthesis cause alopecia with intellectual disability, a rare recessive neuroectodermal syndrome.
Besnard, Thomas; Sloboda, Natacha; Goldenberg, Alice; Küry, Sébastien; Cogné, Benjamin; Breheret, Flora; Trochu, Eva; Conrad, Solène; Vincent, Marie; Deb, Wallid; Balguerie, Xavier; Barbarot, Sébastien; Baujat, Geneviève; Ben-Omran, Tawfeg; Bursztejn, Anne-Claire; Carmignac, Virginie; Datta, Alexandre N; Delignières, Aline; Faivre, Laurence; Gardie, Betty; Guéant, Jean-Louis; Kuentz, Paul; Lenglet, Marion; Nassogne, Marie-Cécile; Ramaekers, Vincent; Schnur, Rhonda E; Si, Yue; Torti, Erin; Thevenon, Julien; Vabres, Pierre; Van Maldergem, Lionel; Wand, Dorothea; Wiedemann, Arnaud; Cariou, Bertrand; Redon, Richard; Lamazière, Antonin; Bézieau, Stéphane; Feillet, Francois; Isidor, Bertrand.
Afiliación
  • Besnard T; CHU de Nantes, Service de Génétique Médicale, Nantes, France. thomas.besnard@chu-nantes.fr.
  • Sloboda N; L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France. thomas.besnard@chu-nantes.fr.
  • Goldenberg A; INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.
  • Küry S; Department of Genetics, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.
  • Cogné B; CHU de Nantes, Service de Génétique Médicale, Nantes, France.
  • Breheret F; L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
  • Trochu E; CHU de Nantes, Service de Génétique Médicale, Nantes, France.
  • Conrad S; L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
  • Vincent M; CHU de Nantes, Service de Génétique Médicale, Nantes, France.
  • Deb W; CHU de Nantes, Service de Génétique Médicale, Nantes, France.
  • Balguerie X; CHU de Nantes, Service de Génétique Médicale, Nantes, France.
  • Barbarot S; CHU de Nantes, Service de Génétique Médicale, Nantes, France.
  • Baujat G; L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
  • Ben-Omran T; CHU de Nantes, Service de Génétique Médicale, Nantes, France.
  • Bursztejn AC; L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
  • Carmignac V; Department of Dermatology, University Hospital Center of Rouen, Rouen, France.
  • Datta AN; CHU de Nantes, Department of Dermatology, Nantes, France.
  • Delignières A; Department of Medical Genetics, INSERM UMR 1163, Paris Descartes-Sorbonne Paris Cité University, IMAGINE Institute, Necker Enfants Malades Hospital, Paris, France.
  • Faivre L; Section of Clinical and Metabolic Genetics, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.
  • Gardie B; Dermatology department, hôpital Brabois, Vandœuvre-Lès, Vandœuvre-lès-Nancy, France.
  • Guéant JL; Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
  • Kuentz P; UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France.
  • Lenglet M; Department of Pediatric Neurology and Developmental Medicine, University of Basel Children's Hospital (UKBB), Basel, Switzerland.
  • Nassogne MC; CH Auray-Vannes, Hôpital Bretagne Atlantique, Service de Pediatrie, Vannes, France.
  • Ramaekers V; Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
  • Schnur RE; UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France.
  • Si Y; L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
  • Torti E; Ecole Pratique des Hautes Etudes, PSL Research University, Paris, France.
  • Thevenon J; INSERM, UMR 1256 Nutrition-Genetics-Environmental Risk Exposure and Reference Centre of Inborn Metabolism Diseases, University of Lorraine and University Hospital Centre of Nancy (CHRU Nancy), Nancy, France.
  • Vabres P; Centre de Genetique et Centre de Reference Anomalies du Développement et Syndromes Malformatifs de l'Est, FHU-TRANSLAD, CHU Dijon, Dijon, France.
  • Van Maldergem L; UMR-Inserm 1231 GAD Team, Genetique des Anomalies du Développement, Université de Bourgogne Franche-Comte, Dijon, France.
  • Wand D; L'institut du thorax, INSERM, CNRS, UNIV Nantes, CHU de Nantes, Nantes, France.
  • Wiedemann A; Ecole Pratique des Hautes Etudes, PSL Research University, Paris, France.
  • Cariou B; Pediatric Neurology Unit, Cliniques Universitaires Saint-Luc, Universite Catholique de Louvain, Brussels, Belgium.
  • Redon R; Center of Autism and Department of Genetics, University Hospital Liege (CHU), Liège, Belgium.
  • Lamazière A; GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
  • Bézieau S; GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
  • Feillet F; GeneDx, 207 Perry Parkway, Gaithersburg, MD, USA.
  • Isidor B; Centre de Génétique, Hôpital Couple-Enfant, CHU de Grenoble-Alpes, La Tronche, France.
Genet Med ; 21(9): 2025-2035, 2019 09.
Article en En | MEDLINE | ID: mdl-30723320
ABSTRACT

PURPOSE:

Lanosterol synthase (LSS) gene was initially described in families with extensive congenital cataracts. Recently, a study has highlighted LSS associated with hypotrichosis simplex. We expanded the phenotypic spectrum of LSS to a recessive neuroectodermal syndrome formerly named alopecia with mental retardation (APMR) syndrome. It is a rare autosomal recessive condition characterized by hypotrichosis and intellectual disability (ID) or developmental delay (DD), frequently associated with early-onset epilepsy and other dermatological features.

METHODS:

Through a multicenter international collaborative study, we identified LSS pathogenic variants in APMR individuals either by exome sequencing or LSS Sanger sequencing. Splicing defects were assessed by transcript analysis and minigene assay.

RESULTS:

We reported ten APMR individuals from six unrelated families with biallelic variants in LSS. We additionally identified one affected individual with a single rare variant in LSS and an allelic imbalance suggesting a second event. Among the identified variants, two were truncating, seven were missense, and two were splicing variants. Quantification of cholesterol and its precursors did not reveal noticeable imbalance.

CONCLUSION:

In the cholesterol biosynthesis pathway, lanosterol synthase leads to the cyclization of (S)-2,3-oxidosqualene into lanosterol. Our data suggest LSS as a major gene causing a rare recessive neuroectodermal syndrome.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Discapacidades del Desarrollo / Colesterol / Transferasas Intramoleculares / Alopecia / Discapacidad Intelectual Tipo de estudio: Clinical_trials Límite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Discapacidades del Desarrollo / Colesterol / Transferasas Intramoleculares / Alopecia / Discapacidad Intelectual Tipo de estudio: Clinical_trials Límite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2019 Tipo del documento: Article País de afiliación: Francia